![Harold Jacobi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Harold Jacobi
Anciens postes connus de Harold Jacobi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Deciphera Pharmaceuticals LLC
![]() Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 30/03/2009 | - |
Corporate Officer/Principal | 25/03/2009 | 30/03/2009 |
Formation de Harold Jacobi
University of Virginia | Undergraduate Degree |
Boston University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Israël | 2 |
Opérationnelle
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Deciphera Pharmaceuticals LLC
![]() Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Harold Jacobi
- Expérience